Mark A. Hillman
Hillman Value Fund
Hillman Value Fund 13F holdings
Mark A. Hillman's Portfolio
- Portfolio value:
- $228.79M≈
- # of securities:
- 38
- Reported for:
- 30 Sep 2024 (Q3)
- Latest filing date:
- 27 Nov 2024
What was Mark A. Hillman's 2024 Q3 portfolio?
Hillman Value Fund has disclosed a total of 38 security holdings in their (2024 Q3) SEC filing(s) with portfolio value of $228,789,066.
Hillman Value Fund's portfolio holdings are tracked quarterly based on SEC filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Mark A. Hillman's original SEC reports (2024 Q3) are the official SEC institutional disclosure documents covering all reported equity positions.
38 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Company
|
3.48%
|
154,000
|
$51.74
|
+27.97%($66.21)
|
$7,967,960
|
2024 Q2
|
≈ 0.50 years
|
Common Stock
|
|
|
|
|
|
MONEY MARKET FIDUCIA
|
3.33%
|
7,623,486.84
|
$1.00
|
|
$7,623,487
|
2020 Q1
|
≈ 4.75 years
|
Mutual Fund
|
-21.65% (-2.11M)
|
-0.93%
|
|
|
|
U.S. Bancorp
|
3.12%
|
156,000
|
$45.73
|
+41.76%($64.82)
|
$7,133,880
|
2023 Q3
|
≈ 1.25 years
|
Common Stock
|
|
|
|
|
|
AT&T Inc
|
2.99%
|
310,600
|
$22.00
|
+6.55%($23.44)
|
$6,833,200
|
2020 Q1
|
≈ 4.75 years
|
Common Stock
|
|
|
|
|
|
Dupont De Nemours Inc
|
2.96%
|
25,300
|
$267.33
|
|
$6,763,449
|
2020 Q1
|
≈ 4.75 years
|
Common Stock
|
|
|
|
|
|
Campbells Co
|
2.95%
|
137,800
|
$48.92
|
-53.61%($22.70)
|
$6,741,176
|
2024 Q1
|
≈ 0.75 years
|
Common Stock
|
|
|
|
|
|
Nike Inc
|
2.92%
|
75,500
|
$88.40
|
-52.87%($41.66)
|
$6,674,200
|
2024 Q1
|
≈ 0.75 years
|
Common Stock
|
+19.84% (+12.5K)
|
+0.48%
|
|
|
|
Warner Bros Discovery Inc
|
2.91%
|
808,000
|
$8.25
|
+216.73%($26.13)
|
$6,666,000
|
2022 Q2
|
≈ 2.50 years
|
Common Stock
|
|
|
|
|
|
International Flavors & Fragrances Inc
|
2.88%
|
62,900
|
$104.93
|
-23.07%($80.72)
|
$6,600,097
|
2023 Q2
|
≈ 1.50 years
|
Common Stock
|
|
|
|
|
|
Pfizer Inc
|
2.80%
|
221,200
|
$28.94
|
-11.94%($25.48)
|
$6,401,528
|
2023 Q4
|
≈ 1.00 year
|
Common Stock
|
|
|
|
Completely sold out
2 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
BANK OF NEW YORK MELLON CORP
|
-107,200
|
-2.83%
|
2020 Q4
|
≈ 3.75 years
|
|
|
|
Kellanova
|
-98,400
|
-2.5%
|
2020 Q1
|
≈ 4.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.